Adam S Kittai

17PUBLICATIONS
130CO-AUTHORS
Molecular targetsPredictive and prognostic markersSolid tumoursHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 14, 2026
Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22.

|Apr 29, 2026
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.

|Nov 05, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia.

Britten K Gordon, Elizabeth M Muhowski, Jyotsana Singh

|Dec 23, 2024
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma.

Swetha Kambhampati Thiruvengadam, Reid Merryman, Yan Wang

|Aug 17, 2024
Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation.

John Alan Gambril, Sanam M Ghazi, Stephen Sansoterra

|Mar 29, 2024
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.

Adam S Kittai, David Bond, Ying Huang

Pageof 3

Frequent Collaborators

11 joint publications

Jennifer Woyach

4 joint publications

Kerry A Rogers

3 joint publications

Matthew S Davids

2 joint publications

William Wierda